NIH Gene Therapy AE Reporting Proposal Adopts FDA Reporting Requirements
Executive Summary
NIH's proposed gene therapy adverse event reporting plan would harmonize reporting requirements between NIH and FDA by adopting FDA gene therapy AE reporting procedures.